Related Experiment Video
Updated: Feb 3, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
Published on: February 15, 2019
Lin-CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade
Catherine T Flores1, Tyler J Wildes2, Jeffrey A Drake2
1University of Florida Brain Tumor Immunotherapy Program, Preston A. Wells, Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, 1149S Newell Dr, L2-100, Gainesville, FL, 32611, USA. catherine.flores@neurosurgery.ufl.edu.
Abstract:
Immune checkpoint blockade using anti-PD-1 monoclonal antibodies has shown considerable promise in the treatment of solid tumors, but brain tumors remain notoriously refractory to treatment. In CNS malignancies that are completely resistant to PD-1 blockade, we found that bone marrow-derived, lineage-negative hematopoietic stem and progenitor cells (HSCs) that express C-C chemokine receptor type 2 (CCR2+) reverses treatment resistance and sensitizes mice to curative immunotherapy. HSC transfer with PD-1 blockade increases T-cell frequency and activation within tumors in preclinical models of glioblastoma and medulloblastoma. CCR2+HSCs preferentially migrate to intracranial brain tumors and differentiate into antigen-presenting cells within the tumor microenvironment and cross-present tumor-derived antigens to CD8+ T cells. HSC transfer also rescues tumor resistance to adoptive cellular therapy in medulloblastoma and glioblastoma. Our studies demonstrate a novel role for CCR2+HSCs in overcoming brain tumor resistance to PD-1 checkpoint blockade and adoptive cellular therapy in multiple invasive brain tumor models.
Insights
Hematopoietic stem cells (HSCs) expressing C-C chemokine receptor type 2 (CCR2+) overcome resistance to immunotherapy in brain tumors. This approach sensitizes models of glioblastoma and medulloblastoma to curative treatment.
Area of Science:
- Immunology
- Neuro-oncology
- Stem Cell Biology
Background:
- Immune checkpoint blockade with anti-PD-1 antibodies shows promise for solid tumors but is ineffective against brain tumors.
- Central nervous system (CNS) malignancies are often resistant to current immunotherapeutic strategies.
Purpose of the Study:
- To investigate the potential of hematopoietic stem and progenitor cells (HSCs) to overcome resistance to immunotherapy in brain tumors.
- To explore the role of C-C chemokine receptor type 2 (CCR2)-expressing HSCs in sensitizing brain tumors to PD-1 blockade and adoptive cellular therapy.
Main Methods:
- Utilized preclinical models of glioblastoma and medulloblastoma.
- Administered bone marrow-derived, lineage-negative HSCs expressing CCR2 (CCR2+ HSCs) in combination with PD-1 blockade.
- Analyzed T-cell frequency, activation, and differentiation of HSCs into antigen-presenting cells within the tumor microenvironment.
Main Results:
- CCR2+ HSC transfer reversed resistance to PD-1 blockade in CNS malignancies.
- HSC transfer enhanced T-cell frequency and activation within intracranial tumors.
- CCR2+ HSCs migrated to brain tumors, differentiated into antigen-presenting cells, and cross-presented tumor antigens to CD8+ T cells, sensitizing tumors to immunotherapy.
Conclusions:
- CCR2+ HSCs represent a novel therapeutic strategy to overcome brain tumor resistance to PD-1 checkpoint blockade.
- HSC transfer can sensitize invasive brain tumors, including glioblastoma and medulloblastoma, to both PD-1 blockade and adoptive cellular therapy.
More Related Videos
12:20Analysis of Hematopoietic Stem Progenitor Cell Metabolism
Published on: November 9, 2019
07:17Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps
Published on: July 30, 2019
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells
Neuromuscular Junction And Blockade
Adult Stem Cells
Embryonic Stem Cells
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...